BackAIkido Pharma Overview

AIkido Pharma Long Term Debt

AIkido Pharma's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
100.00% YoYΔ $-2.44M vs prior year quarter

Peer trimmed avg / median

Loading

AIkido Pharma Long Term Debt History

Loading

AIkido Pharma vs. peers: Long Term Debt Comparison

Loading

AIkido Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AIkido Pharma (AIKI) FAQ

As of the most recent data (June 2026), AIKI shows a long-term debt of $0. That compares with $2.4M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AIKI's long-term debt is now $0 (was $2.4M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AIkido Pharma is outperforming or lagging.

Tracking AIKI's long-term debt over time shows whether AIkido Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $2.4M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has AIkido Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

AIkido Pharma's long-term debt is $0; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.